Login Register Cart 0
Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

COVID-19 Vaccine Practices and Perceptions Among an Academic Healthcare Community

Author(s): Samiksha Prasad, Waseem Wahood, Darisel Ventura Rodriguez and Amanda J. Chase*

Volume 4, Issue 3, 2023

Published on: 09 October, 2023

Article ID: e091023221908 Pages: 10

DOI: 10.2174/0126667975259369230921054259

Price: $65

conference banner
Abstract

Background: Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. The COVID-19 pandemic served as a driving force for the evaluation of nextgeneration vaccine technology platforms through novel paradigms to accelerate vaccine development and administration. However, vaccine acceptance is influenced by many factors, including social influences and community-based interventions.

Objective: This study aimed to assess the impact of the COVID-19 pandemic and vaccination climate on an academic health professions community of students, faculty, and staff.

Methods: An anonymous, 29-item survey was developed with questions pertaining to demographics, COVID-19 infection, vaccine practices and hesitancy. A total of 583 students, faculty, and staff from multiple health professions at a single academic institution completed the survey.

Results: A higher number of students agreed that they “feel socially pressured to get the COVID-19 vaccine” as compared to faculty/staff (39.3% vs. 18.2%, p<0.001). In addition, a lower number of students agreed that “the benefits of vaccination outweigh the risks” compared to faculty/staff (85.9% vs. 92.8%, p=0.039). Moreover, a lower number of students disagreed with the statement “healthcare workers/students should have the right to refuse the COVID-19 vaccine that is required by their employer/ institution” compared to faculty/staff (40.2% vs. 68.9%, p<0.001). These were among 11 of the statistically divergent responses that gaged vaccine hesitancy.

Conclusion: This study provides insight into the perceptions of vaccines from students, faculty, and staff within an interprofessional healthcare community and highlights the need for vaccine education early in health professions curricula.

Graphical Abstract

[1]
Tyrrell DAJ, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet 1966; 287(7428): 76-7.
[http://dx.doi.org/10.1016/S0140-6736(66)92364-6] [PMID: 4158999]
[2]
Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17(3): 181-92.
[http://dx.doi.org/10.1038/s41579-018-0118-9] [PMID: 30531947]
[3]
Santacroce L, Charitos IA, Carretta DM, De Nitto E, Lovero R. The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection. J Mol Med 2021; 99(1): 93-106.
[http://dx.doi.org/10.1007/s00109-020-02012-8] [PMID: 33269412]
[4]
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med 2020; 26(4): 450-2.
[http://dx.doi.org/10.1038/s41591-020-0820-9] [PMID: 32284615]
[5]
Mishra V, Singh V, Jain SK. A recent update on SARS-CoV-2 transmission and its variants: Transmission, pathogenic mechanism, and treatment. Coronaviruses 2023; 4(1): e020123212321.
[http://dx.doi.org/10.2174/2666796704666230102121225]
[6]
Enjuanes L, Zuñiga S, Castaño-Rodriguez C, Gutierrez-Alvarez J, Canton J, Sola I. Molecular basis of coronavirus virulence and vaccine development. Adv Virus Res 2016; 96: 245-86.
[http://dx.doi.org/10.1016/bs.aivir.2016.08.003] [PMID: 27712626]
[7]
Masters PS. The molecular biology of coronaviruses. Adv Virus Res 2006; 66: 193-292.
[http://dx.doi.org/10.1016/S0065-3527(06)66005-3] [PMID: 16877062]
[8]
Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. The spike protein of SARS-CoV - A target for vaccine and therapeutic development. Nat Rev Microbiol 2009; 7(3): 226-36.
[http://dx.doi.org/10.1038/nrmicro2090] [PMID: 19198616]
[9]
Cao Z, Liu L, Du L, et al. Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients. Virol J 2010; 7(1): 299.
[http://dx.doi.org/10.1186/1743-422X-7-299] [PMID: 21047436]
[10]
Zhong X, Yang H, Guo ZF, et al. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. J Virol 2005; 79(6): 3401-8.
[http://dx.doi.org/10.1128/JVI.79.6.3401-3408.2005] [PMID: 15731234]
[11]
Stuart LM. In gratitude for mRNA vaccines. N Engl J Med 2021; 385(15): 1436-8.
[http://dx.doi.org/10.1056/NEJMcibr2111445] [PMID: 34569728]
[12]
Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov 2018; 17(4): 261-79.
[http://dx.doi.org/10.1038/nrd.2017.243] [PMID: 29326426]
[13]
Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2020; 384(5): 403-16.
[PMID: 33378609]
[14]
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383(27): 2603-15.
[http://dx.doi.org/10.1056/NEJMoa2034577] [PMID: 33301246]
[15]
Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19. N Engl J Med 2021; 384(23): 2187-201.
[http://dx.doi.org/10.1056/NEJMoa2101544] [PMID: 33882225]
[16]
Forni G, Mantovani A. COVID-19 vaccines: Where we stand and challenges ahead. Cell Death Differ 2021; 28(2): 626-39.
[http://dx.doi.org/10.1038/s41418-020-00720-9] [PMID: 33479399]
[17]
Banerji A, Wickner PG, Saff R, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: Current evidence and suggested approach. J Allergy Clin Immunol Pract 2021; 9(4): 1423-37.
[http://dx.doi.org/10.1016/j.jaip.2020.12.047] [PMID: 33388478]
[18]
Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27(4): 601-15.
[http://dx.doi.org/10.1038/s41591-021-01283-z] [PMID: 33753937]
[19]
Meeting the challenge of long COVID. Nat Med 2020; 26(12): 1803-3.
[http://dx.doi.org/10.1038/s41591-020-01177-6] [PMID: 33288947]
[20]
MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015; 33(34): 4161-4.
[http://dx.doi.org/10.1016/j.vaccine.2015.04.036] [PMID: 25896383]
[21]
Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur 2021; 1: 100012.
[http://dx.doi.org/10.1016/j.lanepe.2020.100012] [PMID: 33954296]
[22]
SteelFisher GK, Blendon RJ, Caporello H. An uncertain public-encouraging acceptance of Covid-19 vaccines. N Engl J Med 2021; 384(16): 1483-7.
[http://dx.doi.org/10.1056/NEJMp2100351] [PMID: 33657291]
[23]
Ciardi F, Menon V, Jensen JL, et al. Knowledge, attitudes and perceptions of COVID-19 vaccination among healthcare workers of an inner-city hospital in New York. Vaccines 2021; 9(5): 516.
[http://dx.doi.org/10.3390/vaccines9050516] [PMID: 34067743]
[24]
World Health Organization. WHO Coronavirus (COVID-19) dashboard. 2022. Available from:https://covid19.who.int/ (Accessed on Dec 2022)
[25]
Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus Pandemic (COVID-19). 2022. Available from:https://ourworldindata.org/coronavirus (Accessed on Dec 2022)
[26]
Center for Disease Control and Prevention. COVID-19 Vaccine Emergency Use Authorization (EUA) fact sheets for recipients and caregivers. 2022. Available from:https://www.cdc.gov/vaccines/covid-19/eua/index.html (Accessed on Dec 2022)
[27]
Larson HJ, Jarrett C, Schulz WS, et al. Measuring vaccine hesitancy: The development of a survey tool. Vaccine 2015; 33(34): 4165-75.
[http://dx.doi.org/10.1016/j.vaccine.2015.04.037] [PMID: 25896384]
[28]
Center for Disease Control and Prevention. COVID-19 risks and information for older adults. 2022. Available from:https://www.cdc.gov/aging/covid19/ (Accessed on Dec 2022)
[29]
Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 2022; 13(1): 1957.
[http://dx.doi.org/10.1038/s41467-022-29521-z] [PMID: 35413949]
[30]
Center on Budget and Policy Priorities. Tracking the COVID-19 economy’s effects on food, housing, and employment hardships. 2022. Available from:https://www.cbpp.org/research/poverty-and-inequality/tracking-the-covid-19-economys-effects-on-food-housing-and(Accessed on Dec 2022)
[31]
Sahin U, Karikó K, Türeci Ö. mRNA-based therapeutics - developing a new class of drugs. Nat Rev Drug Discov 2014; 13(10): 759-80.
[http://dx.doi.org/10.1038/nrd4278] [PMID: 25233993]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy